Attack rate reductions following berotralstat initiation among US patients with hereditary angioedema in the real-world
真实世界中,美国遗传性血管性水肿患者接受贝罗曲司他治疗后,血管性水肿发作率降低
期刊:Allergy Asthma and Clinical Immunology
影响因子:2.4
doi:10.1186/s13223-025-01005-x
Davis-Lorton, Mark; Tachdjian, Raffi; Lopez-Gonzalez, Lorena; MacKnight, Sean D; Ramasubramanian, Ramya; Laliberté, François; Gillard, Patrick; LiVecchi, Meri; Nestler-Parr, Sandra; Lumry, William R